Nat. Med. 9, 1158β1165 (2003)
Two sentences in this article appeared incorrectly. On page 1164, in the eighth paragraph, the third sentence should read βTo the U937-transplanted SCID mice, 1 mg of either SG/17, YN907 or vehicle was injected intravenously, and 20 mg of either AraC or normal saline was injected intraperitoneally on day 7 of transplantation.β On page 1164, in the eighth paragraph, the fourth sentence should read βTo NOD-SCID mice transplanted with patients' leukemic cells, 2 mg of either SG/17 or YN907 was injected intravenously, and 40 mg of either AraC or normal saline was injected intraperioneally on days 3 and 4 of transplantation.β
Additional information
The online version of the original article can be found at 10.1038/nm909
Rights and permissions
About this article
Cite this article
Matsunaga, T., Takemoto, N., Sato, T. et al. Correction: Corrigendum: Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 11, 578 (2005). https://doi.org/10.1038/nm0505-578b
Issue Date:
DOI: https://doi.org/10.1038/nm0505-578b